Bizzell Awarded Three SAMHSA IDIQ Domains

The Bizzell Group  (Bizzell) is excited to continue its successful partnership with the Substance Abuse and Mental Health Services Administration (SAMHSA) on the SAMHSA Indefinite Delivery Indefinite Quantity (IDIQ) contract through 2022. The firm was awarded three domains as a prime contractor on the IDIQ contract, and teamed with larger firms who were successful on additional domains. The contract is designed to assist SAMHSA in achieving its goal of reducing the impact of substance abuse and mental illness in America’s communities.

As a prime contractor, Bizzell, along with our partners, will provide assistance in three separate domains (Domain III, Domain V and Domain VI):

Domain III—Policy Analysis and Program Related Projects: Bizzell will assist with policy analysis, regulatory policy, developing programs and program support by organizing focus groups and consultations that will shed light on mental illness and substance use disorders, healthcare and behavioral health disparities as well as other health related topics.

Domain V—Technical Assistance and Training Projects: With Domain V, Bizzell will provide technical assistance and training courses for a wide range of topics including needs assessment, program planning, science-based approaches to prevention and treatment, payment and financing strategies, including managed care, disparities and culturally appropriate/responsive practice, trauma, health information technology, performance measurement, evaluation, and clinical and medical programs, practices and research.

Domain VI—Planning, Implementation and Report Support Projects: The focus of Domain VI is to plan and support multiple concurrent events and activities through the entire planning and logistical support lifecycle.

Aside from the three domains that Bizzell was awarded as a prime, the firm will also provide services to SAMHSA on two additional domains as a subcontractor to larger firms.

Domain I—Feasibility, Pilot, and Evaluation Projects: On Domain I, Bizzell employees will assist the prime contractor and SAMHSA on executing feasibility studies that will determine if an organizational activity, treatment service, strategy, survey or statistical study will work as intended. Feasibility is followed by the Pilot, which will assess whether the results of a feasibility study can be successfully scaled under a broader range of circumstances. The final portion is Evaluation, which will measure relevant aspects of program performance.

Domain IV—Communication Projects: Bizzell employees will assist with conceptualizing, planning, researching, designing, implementing and evaluating the effectiveness of communications projects that will increase awareness and educate stakeholders about SAMHSA’s mission to reduce the impact of substance abuse and mental health on America’s communities.

Bizzell Develops Medscape Article on the Interactions Between Dementia, Diabetes and Cardiovascular Disease

The Bizzell Group (Bizzell) has recently developed an article, published on Medscape, which explores the interactions between dementia, diabetes, and cardiovascular disease.  The article, Bidirectional Impact of Alzheimer’s Disease and Common Comorbid Conditions, is available as an online CME activity and was developed under a contract with the U.S. Department of Health and Human Services (HHS), Health Resources and Services Administration (HRSA) in collaboration with the HHS, Office of Women’s Health.

It is intended for primary care providers, neurologists, psychiatrists, geriatricians, and other health care team members and addresses the complexities of treating patients with Alzheimer’s disease and common coexisting conditions, specifically cardiovascular disease (CVD) and diabetes (T2D).

These comorbidities can impact the severity and progression of the disease and require individualized, patient-centered approaches and thoughtful medical reasoning. The module discusses common challenges and considerations in the identification, diagnosis, and treatment of patients with Alzheimer’s disease and T2D or CVD.  Useful diagnostic tools, guidelines, and patient resources are provided.

Bizzell Awarded a Contract to Develop a Curriculum for Treating Alzheimer’s Disease

The Bizzell Group (Bizzell) is pleased to announce that our firm was awarded a multi-year contract with the Health Resources and Services Administration (HRSA) to develop a “Uniform Curriculum for the Identification and Treatment of Alzheimer’s Disease for Primary Care Providers”. In designing a Uniform Curriculum to effectively identify and treat Alzheimer’s disease, Bizzell is developing training along the continuum of learning for health care providers which includes academic and health professional scholastic education for student trainees enrolled in health care training programs (e.g., schools of medicine, nursing, pharmacy, dentistry, and master’s and doctoral-level graduate training programs), continuing medical education and continuing education for geriatric health care professionals.

Alzheimer’s disease is an epidemic that continues to grow as people live to an older age. Experts believe as many as 5.4 million people in the U.S. have Alzheimer’s disease. According to the National Institute on Aging, the number of people with the disease doubles every 5-year interval beyond age 65. Government projections show that the number of people ages 65 and older in the United States is expected to grow from 40 million in 2010 to 72.1 million in 2030.

“Our company is honored to lead this important national effort for the Health Resources and Services Administration”, said Anton Bizzell, MD, CEO of Bizzell. “Alzheimer’s disease was the contributing factor in the loss of both my maternal grandmother and great-grandmother and the work is clearly needed with the number of Americans living with Alzheimer’s disease expected to more than triple by 2050.”